- Product NameUNC-0642
- Brief DescriptionInhibitors
- Purification98.00%
- Biological ActivityThe methylation of lysine residues on histones plays a central role in determining euchromatin structure and gene expression. The histone methyltransferases G9a and G9a-like protein (GLP) can mono- or dimethylate lysine 9 on histone 3, contributing to early embryogenesis, genomic imprinting, and lymphocyte development.1,2,3 UNC0642 is a selective inhibitor of G9a and GLP that competitively inhibits binding of H3K9 substrates with a Ki = 3.7 nM. It exhibits >2,000-fold selectivity over the lysine methyltransferase EZH2 and >20,000-fold selectivity over other methyltransferases. UNC0642 has been shown to reduce H3K9 dimethylation levels in MDA-MB-231 and PANC-1 cells with IC50 values of 110 and 40 nM, respectively. Furthermore, it displays improved pharmacokinetic properties relative to UNC0638 (Item No. 10734). See the Structural Genomics Consortium (SGC) website for more information.
- Target NameHistone Methyltransferase inhibitor
- CAS No. 1481677-78-4
- Calculated MW 546.69
- Formulation C29H44F2N6O2
- Storage 3 years -20˚C powder;2 years -80˚C in solvent;
